Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

Recruiting NCT06807268

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

Conditions: Eczema

Sex: All

Ages: 6 Years – 11 Years

Healthy volunteers: No

Phase: PHASE3

Enrollment: 150

Sponsor: Pfizer

Location: Cahaba Dermatology & Skin Health Center, LLC Birmingham Alabama

This research study is being conducted to find out if the test medicine, abrocitinib, improves eczema and is safe for children 6 to \

Inclusion Criteria Children aged 6 to \

Interested in this study? View the official listing for contact and enrollment details.

Source: ClinicalTrials.gov (NCT06807268). StuddyBuddy aggregates publicly available trial information.